Table 4.
Descriptive analysis of antineoplastic dose errors
Underdosage | Overdosage | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Percentage of error1 | < 10 | [10-50[ | [50-100] | > 100 | < 10 | [10-50[ | [50-100] | > 100 | Total | Frequency of drug prescriptions (%) |
Bevacizumab | - | - | 2 | - | 1 | - | - | - | 3 | 0.65 |
Bleomycin | - | - | - | - | - | 3 | - | - | 3 | 3.1 |
Bortezomib | 1 | - | - | - | - | 3 | 1 | - | 5 | 3.36 |
Carboplatin | 4 | 9 | 1 | - | 5 | 14 | 2 | - | 35 | 2.66 |
Cetuximab | - | - | - | - | - | - | 2 | - | 2 | 0.99 |
Cisplatin | - | - | - | - | - | 2 | 1 | 3 | 6 | 5.22 |
Cyclophosphamide | 1 | 2 | 1 | - | 1 | 2 | 1 | - | 8 | 6.31 |
Cytarabine | - | 1 | - | - | - | - | - | - | 1 | 3.23 |
Dacarbazine | - | - | - | - | - | 1 | - | - | 1 | 1.71 |
Docetaxel | - | - | - | - | - | 2 | - | 1 | 3 | 2.69 |
Doxorubicin | - | - | 1 | - | 2 | - | - | 1 | 4 | 8.04 |
Drug in clinical trial | - | - | 1 | - | - | 1 | - | - | 2 | 0.5 |
Liposomal doxorubicin | - | - | - | - | - | 2 | - | - | 2 | 0.31 |
Epirubicin | - | - | 1 | - | - | - | - | - | 1 | 0.6 |
Etoposide | 1 | 1 | - | - | 1 | 1 | - | 1 | 5 | 7.82 |
Fluorouracil | 4 | - | 1 | - | 4 | 9 | 1 | - | 19 | 12.1 |
Gemcitabine | - | 1 | - | - | - | 5 | 3 | 1 | 10 | 4.91 |
Ifosfamide | - | 2 | 2 | - | 2 | 2 | - | - | 8 | 2.67 |
Irinotecan | 1 | - | - | - | 1 | 1 | - | 1 | 4 | 2.57 |
Methotrexate | - | - | 1 | - | - | 1 | - | - | 2 | 1.6 |
Oxaliplatin | 1 | 2 | - | - | 1 | 7 | 1 | 1 | 13 | 2.15 |
Paclitaxel | 1 | - | - | - | - | 3 | - | - | 4 | 1.63 |
Raltitrexed | - | - | - | - | - | - | 1 | - | 1 | 0.1 |
Rituximab | - | 2 | - | - | 4 | - | 1 | - | 7 | 8.21 |
Trastuzumab | - | 1 | 1 | - | - | - | - | - | 2 | 1.78 |
Vinblastine | - | - | - | - | 1 | 1 | - | 1 | 3 | 2.01 |
Vincristine | - | - | - | - | 1 | 4 | 3 | - | 8 | 5.18 |
Vindesine | - | - | - | - | 1 | - | - | - | 1 | 0.75 |
Vinorelbine | - | - | - | - | - | 2 | 1 | 1 | 4 | 2.12 |
Total | 14 | 21 | 12 | - | 25 | 66 | 18 | 11 | 167 |
1 Percentage of error = (theoretical dose - incorrect dose)/theoretical dose *100